Hackensack, NJ, United States of America

Brian Speicher

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Pharmos Corporation. Active years: 2016.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian Speicher: Innovator in Serum Uric Acid Management

Introduction

Brian Speicher is a notable inventor based in Hackensack, NJ (US). He has made significant contributions to the field of medicine, particularly in the management of serum uric acid levels. His innovative approach has the potential to impact the health of many individuals suffering from related conditions.

Latest Patents

Brian Speicher holds a patent for a method of lowering serum uric acid levels using (S)-tofisopam. This enantiomerically-pure compound is administered to effectively lower serum uric acid levels in mammals. His work in this area demonstrates a commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Brian is associated with Pharmos Corporation, where he applies his expertise in pharmaceutical innovation. His role at the company allows him to contribute to the development of new therapeutic solutions. With a patent portfolio that includes 1 patent, he has established himself as a valuable asset in the field.

Collaborations

Throughout his career, Brian has worked alongside talented colleagues such as Judi Gidner and Karen Raudibaugh. These collaborations have fostered a creative environment that encourages the development of groundbreaking medical solutions.

Conclusion

In summary, Brian Speicher is an accomplished inventor whose work in lowering serum uric acid levels showcases his dedication to improving health outcomes. His contributions to Pharmos Corporation and the medical field are commendable and reflect his innovative spirit.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…